STM1344 favors sessility by repressing the expression of the two phosphodiesterases , STM3611 , required for the downregulation of CsgD expression .
YdiV also indirectly contributes to the activation of CsgD mediated biofilm formation through inhibition of the c-di-GMP phosphodiesterase STM3611 .
STM3611 inhibit CsgD function .